Avalo Therapeutics, Inc.·4

Oct 2, 4:11 PM ET

Jain Rita 4

4 · Avalo Therapeutics, Inc. · Filed Oct 2, 2025

Insider Transaction Report

Form 4
Period: 2025-09-30
Jain Rita
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-09-30+1,5721,572 total
    Exercise: $12.71Exp: 2035-09-30Common Stock (1,572 underlying)
Footnotes (1)
  • [F1]The options were granted on September 30, 2025, and are 100% vested.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT